Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD

Polina Putrik*, Sofia Ramiro, Elisabeth Lie, Andras P. Keszei, Tore K. Kvien, Desiree van der Heijde, Robert Landewe, Till Uhlig, Annelies Boonen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1217-1224
Issue number7
Publication statusPublished - Jul 2016


  • rheumatic diseases
  • epidemiology
  • biological therapies
  • health policies
  • attitude of health professionals

Cite this